- AU$75.09m
- AU$71.04m
- AU$1.05m
- 45
- 76
- 78
- 72
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.293 | 0.281 | 38.6 | 0.599 | 1.05 |
Cost of Revenue | |||||
Gross Profit | -0.025 | -0.095 | — | — | — |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 3.12 | 6.52 | 63.6 | 5.37 | 3.79 |
Operating Profit | -2.83 | -6.24 | -25 | -4.77 | -2.74 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -1.58 | -6.39 | -32.1 | -4.86 | -2.77 |
Provision for Income Taxes | |||||
Net Income After Taxes | -1.58 | -6.39 | -32 | -4.49 | -2.77 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -1.58 | -6.39 | -32 | 22.8 | -41.4 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -1.58 | -6.39 | -32 | 22.8 | -41.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.034 | -0.031 | -0.037 | -0.007 | -0.004 |
Special Dividends per Share |